
ProAssurance (PRA) Stock Forecast & Price Target
ProAssurance (PRA) Analyst Ratings
Bulls say
ProAssurance Corp has demonstrated a notable increase in net investment income, reporting a rise of 9.0% to $37.0 million compared to $33.9 million in the prior year, which reflects a strong performance that surpassed both internal estimates and consensus expectations. The company's top-line results exceeded expectations, supported by stable premiums within its medical malpractice segment, a key driver of revenue. Despite experiencing declines in other lines of business, the stability in the medical malpractice segment provides a solid foundation for future financial performance, contributing to a positive outlook for ProAssurance's stock.
Bears say
ProAssurance Corp experienced a decline in net premiums written, reporting a decrease of 2.3% to $276.1 million, which fell short of both internal estimates of $282.7 million and the consensus forecast of $279.9 million. This reduction marks a continuation of disappointing revenue performance compared to the previous year’s $282.7 million. Additionally, the underwriting results were significantly worse than expected, further contributing to a negative outlook for the company's financial future.
This aggregate rating is based on analysts' research of ProAssurance and is not a guaranteed prediction by Public.com or investment advice.
ProAssurance (PRA) Analyst Forecast & Price Prediction
Start investing in ProAssurance (PRA)
Order type
Buy in
Order amount
Est. shares
0 shares